Skip to content
Menu

C4 Therapeutics, Inc. CCCC

Full chart Compare
Set alert

Price alert · CCCC

All alert types
2.48 USD +0.04 (+1.64%)

Regular-session close

2.37 -0.11 -4.42%

After hours · Nov 20, 4:22 PM ET

2.32 Day range 2.55
1.69 52-week range 5.17
YTD
+29.84%
1 year
+4.20%

CCCC revenue history

Revenue is income from the company’s ordinary business activities.

35,947,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20252025-12-3135,947,000363,0001.02%
FY 20242024-12-3135,584,00014,828,00071.44%
FY 20232023-12-3120,756,000-10,340,000-33.25%
FY 20222022-12-3131,096,000-14,689,000-32.08%
FY 20212021-12-3145,785,00012,590,00037.93%
FY 20202020-12-3133,195,00011,814,00055.25%
FY 20192019-12-3121,381,0002,017,00010.42%
FY 20182018-12-3119,364,000Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-05-22T14:42:43.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.